【CDC建议50岁以上的人应接种肺炎球菌疫苗】美国疾病控制与预防中心(CDC)于10月23日宣布一项新的建议,呼吁50岁及以上的人接种肺炎球菌疫苗(pneumococcal vaccine),以预防可能引发肺炎及其他严重疾病的细菌感染。此次建议是由CDC的科学顾问小组提出,并获得了CDC主任科恩博士(Mandy Cohen)的正式批准。这一改变将老年人接种...
Pfizer COVID-19 vaccine. Courtesy: Pfizer The U.S. Centers for Disease Control and Prevention on Wednesday recommended expanding the use of vaccines to adults between 50-64 years to protect against pneumococcal disease. The agency's earlier recommendation for vaccination was for adults 65 years ...
An adult pneumonia vaccine protects against almost all pneumococcal bacteria that can cause pneumonia, bloodstream infections, and meningitis. Pneumococcal pneumonia can be severe and deadly, killing about 50,000 adults every year. It can also cause bacterial meningitis. The are two kinds of these v...
[1]Merck's Capvaxive gears up to challenge Pfizer's dominant Prevnar with CDC panel backing.By Zoey Becker.Jun 28, 2024 11:44am. [2]Merck’s pneumococcal vaccine gets CDC panel backing.By Delilah Alvarado.Published June 28, 2024. 识别微信二维码,添加生物制品圈小编,符合条件者即可加入 生物制...
Understanding the potential risks associated with pneumococcal disease, the CDC’s Advisory Committee on Immunization Practices (ACIP) provided newrecommendations to improve vaccine coverage and protection among adults. Previously, the committee recommended up to two doses of the PPSV23 vaccine...
Science, Not Politics, Should Guide CDC Vaccine Decisions October 15, 2024 A panel at the Centers for Disease Control and Prevention (CDC) that advises the U.S. government on vaccine policy is expected to recommend lowering the age from 65 to 50 for getting a routine pneumococcal vaccination....
vaccine has to be taken on a yearly basis due to the decline in immunity after the year or changes in viral strains. The current pneumococcal vaccine includes 23 antigens and can confer 85-90 percent protection from various types of pneumococcal infections. These vaccines are highly beneficial ...
All smokers should receive the pneumococcal vaccine, advisors to the US Centers for Disease Control and Prevention (CDC) recommended in October. It is the
A Centers for Disease Control and Prevention (CDC) committee has recommended Prevnar 13 [Pneumococcal 13-valent Conjugate Vaccine] for routine use to help protect adults aged 65 years and older against pneumococcal disease, Pfizer announced.M. LoweryAdvanstar Communications Inc...
Cohen also endorsed an advisory committee recommendation to lower the age for a pneumococcal vaccine from 65 to 50. The shot protects against pneumonia and other ailments. “Lowering the age for pneumococcal vaccination gives more adults the opportunity to protect themselves from pne...